NR0B2 and neoplasm: The fractions at the optimum effective concentrations (200 μg/mL SHP-1.7, 400 μg/mL SHP-1.0, 100 μg/mL SLP-1.3, 200 μg/mL SLP-1.3, and 100 μg/mL UPP-0.5) were chosen along with their corresponding tumor cells to measure their apoptosis-inducing effects.